Our TerraWell program is available starting at just $219 + desired GLP-1 medication costs for the first month, with the option to cancel whenever you choose. The program includes consultations with expert MDs, tailored prescriptions (excluding the cost of medications), dedicated nnationally board certified coaching, and necessary lab work (if the required tests haven't been completed in the past 12 months).

Your delivery will be timely, following a thorough assessment by our medical team and the issuance of your prescription, typically within 5 to 7 days. Our process ensures a consistent supply of medication every month for your continued progress.

Please refer to our educational videos on GLP1 Injection How-to for guidance on subcutaneous injection. If you encounter any issues or have questions, please consult your doctor through our support platform.

Yes! We accept both HSA and FSA cards as forms of payment.

Weight reduction varies from person to person. Patients commonly report losing 10-15%+ of their starting weight, with longer treatment times tending toward more weight loss. For a 200 pound person, that would be 20 to 30 pounds.

When a drug is in shortage, compounders can prepare a compounded version of that drug if they meet certain requirements in the Federal Food, Drug, and Cosmetic (FD&C) Act. You can check for drug shortages on the FDA website.

Pharmacies in the CareGLP network comply strictly with all the regulatory standards established by:

• State boards of pharmacy, which regulate all 503A pharmacies
• FDA, which has oversight for the safety of all active pharmaceutical ingredients
• DEA, that oversees the controlled substances sometimes used in compounded preparations
• USP Convention, that issues practice standards ensuring quality and safety of medications and food
• USP General Chapter <795> provides guidelines for the prevention of contamination and potency variance, preparation process, beyond-use dates, and stability for non-sterile compounding.

Pharmacies in the CareGLP network run quality assurance and quality control checks for every batch of compounded semaglutide prescribed to patients.

Some of these steps include but are not limited to:

• Reviewing and confirming the Active Pharmaceutical Ingredient (API) Certificate of Analysis for all semaglutide base lots, which are received from FDA-registered manufacturers;

• Storing the verified API frozen and sealed until use.

• Compounding with the API under aseptic processes to produce specific lots (vials).

• Holding the vials of compounded semaglutide in quarantine (representative samples are taken for testing).

• Using independent third-party laboratories to test the potency, sterility and endotoxicity of each lot of compounded semaglutide (among other criteria).

• Reviewing the results of these tests and, if satisfactory, releasing the validated vials from quarantine for dispensing.

• Assigning each compounded lot a unique lot number and BUD (Beyond Use Date), which is added to the container and is tracked electronically.

• Scanning the lot information on the product at the time of dispensing, which ties a particular lot number to the patient’s file.